Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etiprednol dicloacetate in acute Crohn's disease
NCT00035503Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jan 2002
- Primary completion
- Jan 2004
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of etiprednol dicloacetate in Crohn's disease, sponsored by Teva Pharmaceutical Industries Ltd.. Started Jan 2002; status: completed.
02
Drugs
etiprednol dicloacetate
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00035503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035503.